Exiqon will present at the UBS Global Life Sciences Conference in New York on 21 September 2011
14-09-11 kl. 14/9 2011 09:45 | Exiqon 17,80 (0,00%)
Se flere nyheder om Exiqon
Exiqon A/S (NASDAQ OMX: EXQ.CO), a leading supplier of high-value gene
expression analysis products, today announced that the company will be
presenting at the UBS Global Life Sciences Conference to be held on 19-21
September 2011 in New York.
Exiqon's presentation is scheduled for Wednesday, 21 September at 9:30 a.m.
(ET) at the Grand Hyatt New York.
Additional information:
Lars Kongsbak, CEO, tel. +45 4566 0888 (cell: +45 4090 2101)
Hans Henrik Chrois Christensen, CFO, tel. +45 4566 0888 (cell: +45 4090 2131)
See the full press release in the attached PDF or at
www.exiqon.com/investor/portal. 
PressRelease_September2011_Presentation_UBS_Conference.pdf
Der er endnu ikke skrevet nogen kommentarer til denne artikel.
Skriv en kommentarer til denne artikel:
Send kommentar
Skriv en kommentarer til denne artikel:
Send kommentar
| PRIS | 17,80 |
|---|---|
| ÆNDRING | 0,00 (0,00%) |
| ÅBEN | 0,00 |
| SIDSTE LUK | 17,80 |
| DEBAT | - |
 |
